BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 25, 2010
View Archived Issues
Medivir identifies NS5B polymerase inhibitors for HCV infection
Read More
HIV-targeting gene therapy shows prolonged viremia control in phase I/II trial
Read More
HCV RNA synthesis inhibitor ATI-0810 exhibits favorable safety and pharmacokinetics in vivo
Read More
Novel focal adhesion kinase inhibitors discovered at AstraZeneca
Read More
Roche identifies new inhibitors of Bruton tyrosine kinase BTK
Read More
Takeda discloses new renin inhibitors for hypertension
Read More
Hutchison MediPharma presents novel epidermal growth factor receptor inhibitors
Read More
Phase III NOV-002 trial in NSCLC fails to meet primary endpoint
Read More
Enzon treats first pediatric cancer patient in phase I PEG-SN38 trial
Read More
New fusion inhibitor shows potent antiviral activity in wild-type and RTI-resistant HIV strains
Read More
DIVA 01 trial data indicate good penetration of raltegravir in genital tract of HIV-infected women
Read More
HSP90 inhibitor STA-9090 targets oncogenic functions of Wilms tumor protein in AML cells
Read More
FDA recommends approval of rifaximin for management of hepatic encephalopathy
Read More
Eisai launches Revovir in the Philippines for chronic hepatitis B
Read More
FDA accepts Arena Pharmaceuticals' lorcaserin NDA for filing
Read More
Basilea enters into global partnership with Astellas for isavuconazole
Read More
Five Prime Therapeutics reports milestone for immunology-related therapeutic program
Read More
Shire receives FDA fast track designation for Replagal
Read More
FDA approves Prevnar 13 for prevention of pneumococcal disease in infants and children
Read More
Evotec and Cubist extend and expand research agreement
Read More
GSK criticizes Senate Committee on Finance's report on Avandia
Read More
U.K. approval granted for HealthLinx's OvPlex trial in ovarian cancer
Read More
Kyowa Hakko Kirin submits NDA in Japan for Abstral in breakthrough cancer pain
Read More
Cleveland BioLabs responds to Department of Defense RFP for CBLB-502
Read More
Anadys reports preliminary phase II results on ANA-598/SOC therapy for hepatitis C
Read More